Best Medication for Gambling Addiction
Naltrexone is the best medication for gambling disorder, with nalmefene as an alternative, both being opioid antagonists supported by double-blind placebo-controlled trials showing reduction in gambling urges and behavior. 1
Primary Recommendation: Opioid Antagonists
The most recent and comprehensive network meta-analysis (2025) demonstrates that nalmefene shows the strongest effect (SMD: -0.86) in reducing gambling severity, followed by naltrexone (SMD: -0.42) 2. Both medications also improve quality of life compared to placebo 2. A 2025 pooled analysis further confirms that opioidergic drugs (naltrexone) demonstrate significant efficacy by the final observation timepoint (10-16 weeks) 3.
Practical Implementation
- Start with naltrexone as it has broader availability and more extensive clinical experience
- Typical dosing: 50-100 mg daily (off-label use)
- Consider nalmefene if naltrexone is unavailable or poorly tolerated
- Monitor for 10-16 weeks before assessing full response 3
Important Caveats About Tolerability
Both naltrexone and nalmefene have significantly higher dropout rates due to side effects compared to placebo (OR: 7.82 and 7.55 respectively) 2. Common side effects include nausea, headache, and gastrointestinal distress. This requires careful patient counseling about expected side effects and close monitoring during initial treatment phases.
Alternative Pharmacological Options
Glutamatergic Agents (Second-Line)
The 2025 pooled analysis shows glutamatergic drugs (N-acetylcysteine, memantine) demonstrate efficacy earlier than opioid antagonists - showing benefit from 4-5 weeks onward 3. These may be considered when:
- Opioid antagonists are contraindicated (e.g., current opioid use)
- Side effects from opioid antagonists are intolerable
- Earlier response is clinically necessary
Serotonergic Agents (Not Recommended)
Despite earlier interest, serotonergic drugs (paroxetine, escitalopram) showed no significant effect compared to placebo in the 2025 pooled analysis 3. Multiple systematic reviews confirm insufficient evidence for SSRIs 4, 5.
Other Agents (Insufficient Evidence)
- Topiramate and olanzapine: Not more efficacious than placebo 2
- Mood stabilizers, antipsychotics: Limited and contradictory evidence 6, 5
Critical Clinical Context
No medication is FDA-approved for gambling disorder - all use is off-label 4, 6. The 2022 Lancet Psychiatry guidelines emphasize that while double-blind placebo-controlled studies support opioid antagonists, there remains "little research on what predicts who will benefit" and "virtually no data regarding how treatment options should be sequenced" 1.
Treatment Algorithm
First-line: Naltrexone 50-100 mg daily
- Counsel about side effects (nausea, GI upset)
- Monitor for 10-16 weeks for full response
- Screen for opioid use (contraindication)
If naltrexone fails or is contraindicated: Consider glutamatergic agents (N-acetylcysteine 1200-2400 mg daily or memantine)
- May show earlier response (4-5 weeks)
- Better tolerated than opioid antagonists
Medication should be combined with psychotherapy (CBT, motivational interviewing) as psychological interventions have established efficacy 1
Common Pitfalls to Avoid
- Do not use SSRIs as monotherapy unless treating comorbid depression - they lack specific efficacy for gambling disorder 3, 5
- Do not prescribe opioid antagonists to patients currently using opioids - risk of precipitated withdrawal
- Do not expect immediate results - full response may take 10-16 weeks 3
- Screen for suicide risk - gambling disorder has alarming association with suicidality that is often overlooked 7